231 related articles for article (PubMed ID: 23171028)
21. Single-cell analysis of circulating tumor cells identifies cumulative expression patterns of EMT-related genes in metastatic prostate cancer.
Chen CL; Mahalingam D; Osmulski P; Jadhav RR; Wang CM; Leach RJ; Chang TC; Weitman SD; Kumar AP; Sun L; Gaczynska ME; Thompson IM; Huang TH
Prostate; 2013 Jun; 73(8):813-26. PubMed ID: 23280481
[TBL] [Abstract][Full Text] [Related]
22. Multigene model for predicting metastatic prostate cancer using circulating tumor cells by microfluidic magnetophoresis.
Cho H; Chung JI; Kim J; Seo WI; Lee CH; Morgan TM; Byun SS; Chung JS; Han KH
Cancer Sci; 2021 Feb; 112(2):859-870. PubMed ID: 33232539
[TBL] [Abstract][Full Text] [Related]
23. Characterization of circulating tumor cells by fluorescence in situ hybridization.
Swennenhuis JF; Tibbe AG; Levink R; Sipkema RC; Terstappen LW
Cytometry A; 2009 Jun; 75(6):520-7. PubMed ID: 19291800
[TBL] [Abstract][Full Text] [Related]
24. Monitoring of lipid storage in Caenorhabditis elegans using coherent anti-Stokes Raman scattering (CARS) microscopy.
Hellerer T; Axäng C; Brackmann C; Hillertz P; Pilon M; Enejder A
Proc Natl Acad Sci U S A; 2007 Sep; 104(37):14658-63. PubMed ID: 17804796
[TBL] [Abstract][Full Text] [Related]
25. Associations between AR-V7 status in circulating tumour cells, circulating tumour cell count and survival in men with metastatic castration-resistant prostate cancer.
Belderbos BPS; Sieuwerts AM; Hoop EO; Mostert B; Kraan J; Hamberg P; Van MN; Beaufort CM; Onstenk W; van Soest RJ; Martens J; Sleijfer S; de Wit R; Mathijssen RHJ; Lolkema MP
Eur J Cancer; 2019 Nov; 121():48-54. PubMed ID: 31542641
[TBL] [Abstract][Full Text] [Related]
26. Excitation parameters optimized for coherent anti-Stokes Raman scattering imaging of myelinated tissue.
Brideau C; Poon KWC; Colarusso P; Stys PK
J Biomed Opt; 2019 Apr; 24(4):1-8. PubMed ID: 31007003
[TBL] [Abstract][Full Text] [Related]
27. Elliptically polarized coherent anti-Stokes Raman scattering microscopy.
Lu F; Zheng W; Huang Z
Opt Lett; 2008 Dec; 33(23):2842-4. PubMed ID: 19037445
[TBL] [Abstract][Full Text] [Related]
28. High-sensitivity vibrational imaging with frequency modulation coherent anti-Stokes Raman scattering (FM CARS) microscopy.
Ganikhanov F; Evans CL; Saar BG; Xie XS
Opt Lett; 2006 Jun; 31(12):1872-4. PubMed ID: 16729099
[TBL] [Abstract][Full Text] [Related]
29. Decreased adhesiveness, resistance to anoikis and suppression of GRP94 are integral to the survival of circulating tumor cells in prostate cancer.
Howard EW; Leung SC; Yuen HF; Chua CW; Lee DT; Chan KW; Wang X; Wong YC
Clin Exp Metastasis; 2008; 25(5):497-508. PubMed ID: 18340425
[TBL] [Abstract][Full Text] [Related]
30. TRAIL-coated leukocytes to kill circulating tumor cells in the flowing blood from prostate cancer patients.
Ortiz-Otero N; Marshall JR; Glenn A; Matloubieh J; Joseph J; Sahasrabudhe DM; Messing EM; King MR
BMC Cancer; 2021 Aug; 21(1):898. PubMed ID: 34362331
[TBL] [Abstract][Full Text] [Related]
31. Label-free delineation of brain tumors by coherent anti-Stokes Raman scattering microscopy in an orthotopic mouse model and human glioblastoma.
Uckermann O; Galli R; Tamosaityte S; Leipnitz E; Geiger KD; Schackert G; Koch E; Steiner G; Kirsch M
PLoS One; 2014; 9(9):e107115. PubMed ID: 25198698
[TBL] [Abstract][Full Text] [Related]
32. Raman microscopy based on doubly-resonant four-wave mixing (DR-FWM).
Weeks T; Wachsmann-Hogiu S; Huser T
Opt Express; 2009 Sep; 17(19):17044-51. PubMed ID: 19770922
[TBL] [Abstract][Full Text] [Related]
33. Identification of enhancer of zeste homolog 2 expression in peripheral circulating tumor cells in metastatic prostate cancer patients: a preliminary study.
Cho KS; Oh HY; Lee EJ; Hong SJ
Yonsei Med J; 2007 Dec; 48(6):1009-14. PubMed ID: 18159594
[TBL] [Abstract][Full Text] [Related]
34. [Circulating tumor cells and prostate cancer prognosis].
Capoun O; Soukup V; Mikulová V; Jančíková M; Honová H; Kološtová K; Zima T; Hanuš T
Cas Lek Cesk; 2014; 153(2):72-7. PubMed ID: 24797777
[TBL] [Abstract][Full Text] [Related]
35. Comparison of circulating MicroRNA 141 to circulating tumor cells, lactate dehydrogenase, and prostate-specific antigen for determining treatment response in patients with metastatic prostate cancer.
Gonzales JC; Fink LM; Goodman OB; Symanowski JT; Vogelzang NJ; Ward DC
Clin Genitourin Cancer; 2011 Sep; 9(1):39-45. PubMed ID: 21723797
[TBL] [Abstract][Full Text] [Related]
36. Circulating Tumor Cells as a Marker for Progression-free Survival in Metastatic Castration-naïve Prostate Cancer.
Josefsson A; Linder A; Flondell Site D; Canesin G; Stiehm A; Anand A; Bjartell A; Damber JE; Welén K
Prostate; 2017 Jun; 77(8):849-858. PubMed ID: 28295408
[TBL] [Abstract][Full Text] [Related]
37. Lipid droplet pattern and nondroplet-like structure in two fat mutants of Caenorhabditis elegans revealed by coherent anti-Stokes Raman scattering microscopy.
Yi YH; Chien CH; Chen WW; Ma TH; Liu KY; Chang YS; Chang TC; Lo SJ
J Biomed Opt; 2014 Jan; 19(1):011011. PubMed ID: 23979461
[TBL] [Abstract][Full Text] [Related]
38. Site-specific cytomorphology of disseminated PC-3 prostate cancer cells visualized in vivo with fluorescent proteins.
Bobek V; Hoffman RM; Kolostova K
Diagn Cytopathol; 2013 May; 41(5):413-7. PubMed ID: 22508666
[TBL] [Abstract][Full Text] [Related]
39. Metabolic reprogramming-based characterization of circulating tumor cells in prostate cancer.
Chen J; Cao S; Situ B; Zhong J; Hu Y; Li S; Huang J; Xu J; Wu S; Lin J; Zhao Q; Cai Z; Zheng L; Wang Q
J Exp Clin Cancer Res; 2018 Jun; 37(1):127. PubMed ID: 29954422
[TBL] [Abstract][Full Text] [Related]
40. The Novel Association of Circulating Tumor Cells and Circulating Megakaryocytes with Prostate Cancer Prognosis.
Xu L; Mao X; Guo T; Chan PY; Shaw G; Hines J; Stankiewicz E; Wang Y; Oliver RTD; Ahmad AS; Berney D; Shamash J; Lu YJ
Clin Cancer Res; 2017 Sep; 23(17):5112-5122. PubMed ID: 28615267
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
